CMS Proposes Approval of Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases New Technology Add-on Payment ...

Sequana Medical announced today that CMS recommended that its Alfapump system become eligible for a new incremental payment.

CMS proposes approval of additional payment for Sequana Medical’s alfapump system in hospital inpatient cases: Ghent, Belgium Tuesday, April 15, 2025, 17:00 Hrs [IST] Sequana Me ...

LIVER cancer is the fourth most common cancer in Malaysia and also the fourth leading cause of cancer-related deaths.

SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not ...

Teresa Tiano was diagnosed with stomach cancer in 2011. Now she's helping others Canadians with "the orphan cancer." ...

Diagnosed with liver cancer, a Hanoi man was overwhelmed with worry and confusion. When his family found a 'miracle healer' ...

In summary, liver cirrhosis is a dangerous illness, but spotting the signs early can lead to better care and a better future.

In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...